Related Experiment Video

Updated: Nov 16, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

3.9K

Epidemiology of cardiomyopathies: essential context knowledge for a tailored clinical work-up

Daniele Pasqualucci1, Attilio Iacovoni2, Vittorio Palmieri3

  • 1Department of Cardiology, Azienda Ospedaliera Brotzu, Piazzale Ricchi 1, 09134, Cagliari, Italy.

European Journal of Preventive Cardiology
|February 24, 2021
PubMed

Insights

Cardiomyopathies (CMPs) are heart muscle disorders. This review examines CMP epidemiology in adults aged 18-55, proposing a diagnostic flowchart to improve diagnosis and assessment in younger populations.

Area of Science:

  • Cardiology
  • Genetics
  • Epidemiology

Background:

  • Cardiomyopathies (CMPs) are primary myocardial disorders excluding other common cardiac conditions.
  • Accurate incidence and prevalence data are crucial for clinical context and identifying under-reporting.
  • Existing estimates predate widespread genetic testing and vary due to diverse data sources.

Purpose of the Study:

  • To review the epidemiology of cardiomyopathies in individuals aged 18 to 55 years.
  • To propose an updated diagnostic flowchart for CMPs in young adults.
  • To reduce misdiagnosis in patients with unexplained cardiac conditions.

Main Methods:

  • Literature review focusing on epidemiology of cardiomyopathies.
  • Analysis of studies published before and after the advent of genetic testing.
  • Development of a structured diagnostic algorithm for CMPs.

Main Results:

  • Current epidemiological data for CMPs are limited by variability in population sources and diagnostic methods.
  • Genetic testing has significantly impacted CMP diagnosis and classification.
  • A need exists for standardized diagnostic approaches in specific age groups.

Conclusions:

  • Epidemiological data on cardiomyopathies require updated methodologies, incorporating genetic insights.
  • A standardized diagnostic flowchart can enhance accuracy for CMPs in the 18-55 age group.
  • Improved diagnostic strategies are essential for managing cardiomyopathies in younger adults.

Keywords:
AetiologyCardiomyopathyEpidemiologyHeartHypertrophy

More Related Videos

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients09:16

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients

Published on: February 28, 2018

7.9K
Real-Time Electrocardiogram Monitoring During Treadmill Training in Mice04:45

Real-Time Electrocardiogram Monitoring During Treadmill Training in Mice

Published on: May 5, 2022

2.7K

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
145
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
206
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
99
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
121
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
147
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
189